Target IOP Update Mohamed Yasser Sayed Saif Beni Suef University

Slides:



Advertisements
Similar presentations
Il controllo circadiano della pressione intraoculare: implicazioni farmacologiche N. ORZALESI, P. FOGAGNOLO Università degli Studi di Milano Ospedale San.
Advertisements

The target IOP is the mean IOP obtained with treatment that prevents further glaucomatous damage in the eye of the individual under consideration. The.
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Clinical Guidance and Monitoring for Change Cecilia Fenerty MD FRCOphth.
Introduction Glaucoma starting from the definition, unknown etiology for the primary cases, glaucoma suspect, ocular hypertension, early detection, diagnosis,
PRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA
0 Glaucoma can take your sight away. Keep Vision in Your Future.
In the name of god Target IOP S.M.Shahshahan M.D Feb 2010.
Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,
4/19/2017 Managing Patients With Ocular Hypertension Results From The Ocular Hypertension Treatment Study (OHTS) The American Glaucoma Society Michael.
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Will my Glaucoma patient lose vision ?
RANDOMIZED CLINICAL TRIALS IN GLAUCOMA- WHAT DO THEY TELL US? Dr Jyoti Shetty B.W.Lions superspeciality eye hospital.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
QUANTITATING THE IMPACT OF CLINICAL AND BASIC SCIENCE RESEARCH POSTER #2469 M. O. GORDON, C. SARLI, E. K. DUBINSKY, E. LONG, C. LA RUE, M. A. KASS, AND.
Update on Prostaglandin Analogues Used for the Treatment of Glaucoma
Universita’ di Catania, Italia Clinica Oculistica Dir.: Prof. A. Reibaldi Purpose: To evaluate the efficacy and safety of Pneumotrabeculoplasty (PNT) in.
Does Greater Long-Term IOP Variability Increase Probability of Primary Open Angle Glaucoma in the Ocular Hypertension Treatment Study (OHTS)? M.O. Gordon,
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
Effect of Corneal Thickness on Selective Laser Trabeculoplasty to Decrease Intraocular Pressure as Primary or Secondary Treatment of Glaucoma ASCRS 2010.
How Do I Know My Glaucoma Treatment is Working? Dr Catherine Green Head: Glaucoma Unit RVEEH.
Effect of Race on Selective Laser Trabeculoplasty  1st author has no financial interest in the subject matter of this poster.  2nd and 3rd co-authors.
Introduction  Selective Laser Trabeculoplasty (SLT) uses a Q-Switched frequency- doubled (532 nm), low energy Nd:YAG laser, which targets melanocytes.
PHACO-TRAB VERSUS PHACO ONLY IN EYES WITH ADVANCED OR END-STAGE GLAUCOMA WITH CONTROLLED INTRAOCULAR PRESSURE AND VISUALLY SIGNIFICANT CATARACT Liaska.
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
E-Poster Rio de Janeiro Corneal Tomography and Biomechanics Study Group The study of the correlations of the optic disc size with Cornal Geometry and Biomechanical.
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
Rate of Visual Field Progression in Eyes With Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study De Moraes CG, Demirel S, Gardiner SK, et.
The Ocular Hypertension Treatment Study Group (OHTS)
Effect of East Asian Race on Selective Laser Trabeculoplasty ASCRS 2011 Minerva Kim Johns Hopkins University Lawrence F. Jindra, MD Columbia University.
Effect of Refractive State on Selective Laser Trabeculoplasty ASCRS 2011 Kevin Lai Stony Brook University School of Medicine Elaine M. Miglino Floral Park.
Bromfenac Sodium Hydrate is Effective in Treating Intraoperative Discomfort during Selective Laser Trabeculoplasty ASCRS 2009 Marie T. Natale Floral Park.
Mr. A. Waldock MD BMed Sci (Hons) BM BS FRCOphth Consultant Ophthalmic Surgeon Ophthalmology Training Programme Director, East of England Deanery.
The Royal Victorian Eye and Ear Hospital 24-hour eye pressure and glaucoma Dr Simon Skalicky FRANZCO, MPhil, MMed (Ophthal Sci), MBBS (Hons 1) Visiting.
Six-Year Longevity of Selective Laser Trabeculoplasty as Primary Therapy in Patients with Glaucoma ASCRS 2009 Lawrence F. Jindra, MD Columbia University.
Effect of Previous Argon Laser Trabeculoplasty on Selective Laser Trabeculoplasty ASCRS 2011 Lawrence F. Jindra, MD Columbia University Winthrop University.
V. Kumar 1,2, M. Frolov 1, I. Shepelova 1,2 Department of ophthalmology, People's friendship university of Russia, Moscow, Russian Federation 1 ; Ophthalmic.
1. Ankara University School of Medicine, Department of Ophthalmology
Surgical Outcomes In Children With Primary Childhood Glaucoma
iStent with phacoemulsification, n=50
María Alejandra Carrasco, MD Mendoza. Argentina
Iwona Helemejko, MD 1; D. Robert Iskander, PhD2
PROTECTING CELLS IN THE EYE AT RISK OF DAMGE FROM GLAUCOMA
Halil Ates1, Suzan Guven Yilmaz1, Murat Erbezci2
Tulsi Changulani 1,*, Jenny Bo 2, Mei-Ling Cheng 1, Andrew Tatham 1
Ocular Manifestations of Diabetes
Selective laser trabeculoplasty in Korean eyes with medically uncontrolled pseudoexfoliation glaucoma Su Chan Lee1, Jung Hyun Lee1,
Ophthalmology – Raised IOP Referrals (Adults only)
Characteristics of Primary Angle-Closure Glaucoma Patients with Normal Intraocular Pressure at the First Visit Won Hyuk Oh1, Bum Gi Kim1, Joo Hwa Lee2.
Safety of medication reduction for Primary Angle Closure (PAC) –
Asymmetry Analysis of Retinal Thickness
Review of Glaucoma Suspect
Early Intraocular Pressure Rise After Phacoemulsification In Non-Glaucomatous And Eyes With Primary Open-Angle Glaucoma Milos Todorovic 1, Suncica Sreckovic.
Neuroretinal Rim Recovery In Narrow Angle Glaucoma After Intraocular Pressure Lowering With Topical Medications  – Case Report Božić M.1,2, Marković V.
Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Year 1 Results Lisa A. Hark, PhD, RD; Michael Waisbourd, MD; Kamran Rahmatnejad, MD;
Effect of Selective Laser Trabeculoplasty on
From: The Effects of Study Design and Spectrum Bias on the Evaluation of Diagnostic Accuracy of Confocal Scanning Laser Ophthalmoscopy in Glaucoma Invest.
Risk stratification and calculators
Glaucoma Clinical features and management
David B Henson Medical School University of Manchester
Glaucoma.
Winthrop University Hospital
Glaucoma Progression.
Clinical Cases in Glaucoma Treatment
Goals & Guidelines A summary of international guidelines for CHD
Diabetic Retinopathy Clinical Research Network
Winthrop University Hospital
The Effect of Corneal Thickness on Ocular Drug Penetration
ASCRS 2010 Joseph A. Donnelly Albert Einstein College of Medicine
Floral Park Ophthalmology Winthrop University Hospital
Presentation transcript:

Target IOP Update Mohamed Yasser Sayed Saif Beni Suef University Cairo University Center of Aging

Co Authors Sayed S E H Saif Cairo University Mostafa Nassar Menofia University Ahmed Tamer Sayed Saif Fayoum university Passant Sayed Saif Must university Hazem Effat Haroun Beni Suef University Safaa Awadalla Nermeen A Abd Elghaffar Fayoum eye hospital Shreif Kamel Safina Co Authors

target intraocular pressure is defined as "the mean intraocular pressure obtained with treatment that prevents further glaucomatous damage" Moustafa Kamal Nassar, M.D. Target Intraocular Pressure http://www.glaucoma-egypt.org/Glaucoma- news/200102.pdf accessed Oct 2014

TARGET IOP: DEFINITION Target IOP may be defined as a pressure, rather a range of intraocular pressure levels within which the progression of glaucoma and visual field loss will be delayed or halted Ref: Surveys of Ophthalmology 2003; 48 (suppl 1): 53-57

Review of Literature

The early-manifest glaucoma treatment study showed that IOP reduction by at least 25% reduced progression from 62 to 45% in the treated group compared to an untreated group Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–79. Rajul S Parikh,  Shefali R Parikh,  Shoba Navin,  Ellen Arun, And Ravi Thomas. Practical approach to medical management of glaucoma; Indian j ophthalmol. 2008 may-jun; 56(3): 223–230

The Collaborative Initial Glaucoma Treatment Study (CIGTS) lowered the IOP by 35%, demonstrated equivalence of medical and surgical treatment, decreased disease progression to less than 15%. Feiner L, Piltz-Seymour JR. Collaborative Initial Glaucoma Treatment Study: A summary of results to date. Curr Opin Ophthalmol. 2003;14:106–11. [PubMed]

IOP lowering needs to be individualized with the goal of preventing any decrease in the QOL during the patient′s lifetime. There is, however, no hard evidence for the concept or the methods used to determine the target. Rajul S Parikh,  Shefali R Parikh,  Shoba Navin,  Ellen Arun, And Ravi Thomas. Practical approach to medical management of glaucoma; Indian j ophthalmol. 2008 may-jun; 56(3): 223–230

factors should be considered at the time of presentation to customize the target IOP: Structural damage: optic disc and RNFL Functional damage on WWP Baseline IOP at which the damage occurred (correlate the above two with baseline IOP). Age Presence of additional risk factors Hodapp E, Parrish RK, 2nd, Anderson DR. St Louis: Mosby and Co; 1993. Clinical decisions in glaucoma; pp. 63–92.

Target IOP has to be individualized based on patient′s clinical profile. This can be calculated using tables, graphs or formulae.

AAO GUIDELINES: TARGET IOP Glaucoma patients with mild damage (optic disc cupping but no visual field loss)  Reduction of 20-30% from baseline Glaucoma patients with advance damage  Reduction of 40% or more from baseline Normal pressure glaucoma  Reduction of 30% from baseline Ocular hypertension  Reduction of 20% from baseline Surveys of Ophthalmology 2003; 48 (suppl 1): 53-57

AAO GUIDELINES: TARGET IOP Open angle glaucoma with IOP in the mid to high 20s Target IOP range 14-18 mmHg Advanced Glaucoma  Target IOP < 15 mmHg OHT whose IOP > 30 mmHg with no sign of optic nerve damage  Target IOP < 20 mmHg Ref: Surveys of Ophthalmology 2003; 48 (suppl 1); 53-57

The formula used CIGTS jample saif Y2=Y0+A1eX/T1 Jample's formula for calculating target IOP. Z = Optic nerve damage Norm disk Norm Field Abnormal Disk Norm Field Field loss not threatening fixation Field loss threatening fixation Y = Burden of therapy No effects on QOL Small effect Moderate effect Large effect

SAIF TABLE Sayed S E H Saif, M Yasser S Saif, Ahmed T.S.Saif; Early Detection of Glaucoma , A New Scoring System. Bull Ophthalmol Soc Egypt, 2005; Vol 98, Number 3, 351-358 Sayed S E H Saif, M Yasser S Saif, Ahmed T S Saif; Target IOP What is New; Bull Ophthalmol Soc Egypt, 2006; Vol 99, Number 3, 445-449 Sayed S E H Saif, M Yasser S Saif, Ahmed T S Saif; Glaucoma is it still a dilemma in the 21st century; Bull Ophthalmol Soc Egypt, 2007; Vol 100, Number 3, 395-399 Sayed S E H Saif, M Yasser S Saif, Ahmed T.S.Saif; Early Detection of Glaucoma , A New Scoring System. Highlights of Ophthalmology website 2005; http://www.elibraryweb.net/index.php?option=com_content&task=category&sectionid=9&id=24&Itemid=59 Sayed S E H Saif, M Yasser S Saif, Ahmed T.S.Saif; Early Detection and Managmant of Glaucoma , A New Scoring System. Highlights of Ophthalmology 2007; Volume 35, Number 6, 2-4 (English Version) Sayed S E H Saif, Moh Yasser S Saif, Ahmed T S Saif ; The Glaucoma suspect, the dilemma. What is new? Bull Ophthalmol Soc Egypt, 2008; Vol 101, Mohamed Yasser Sayed Saif, Ahmed Tamer Sayed Saif, Passant Sayed Saif, Wessam Salah ElDen, The Glaucoma suspect , the dilemma. What is new? Research in Ophthalmology 2013;  2(1): 10-14 doi:10.5923/j.ophthal

Subject and Methods 108 Patients : Females 66 , Males 42 Full Ophthalmic examination Visual Field test OCT Saif Table Follow up : ranged from 9 month – 4.6 yrs

Mean age female male achieved 35.87 44.25 not achieved 46.33 54.33 Grand Total 38.72 48.57

Results

  achievedIOP Yes NO Mean Median Stand Dev IOPdiff 4.73 4.50 2.95 5.10 5.00 6.35 VFdiff -1.90 -1.03 4.92 .27 .03 1.48 VF1 6.691 3.080 7.335 17.687 19.875 9.981 VF2 4.794 2.265 6.515 17.957 19.020 9.335

Conclusion

Target IOP should be individualized as per patient and should be a flexible ever changing variable varying with the progression of the disease The concept of a target IOP should be a part of the standard of care for physicians who treat glaucoma patients The methods used to maintain the target pressure should be sustainable over the long term with minimal adverse effects

Thank you